Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

NCT00251550 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesotherioma

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin

Sponsor

Eli Lilly and Company